Device for Targeted Ovarian Chemo-Protective Drug Delivery
This project has been secured to protect intellectual property.
Login for More InformationProject Overview
Doxorubicin chemotherapy in female patients can result in infertility as a result of induced cellular toxicity in the ovaries. Our client, Dr. Sana Salih, has researched the effects of dexrazoxane (Dexra) in the ovaries to prevent DNA damage during chemotherapy. The goal of this project is to design an endo-bag that will selectively deliver Dexra to the ovaries to prevent non-targeted toxicity.
Team Picture
Contact Information
Team Members
- Ryan Rinehart - Team Leader
- Clair Kurzynski - Communicator
- Kelsey Veserat - BSAC
- Emily Olszewski - BWIG
- Alyssa Acker - BPAG
Advisor and Client
- Prof. Wan-Ju Li - Advisor
- Dr. Sana Salih - Client
Related Projects
- Fall 2014: An endo-pouch for selective targeted ovarian drug delivery in cancer patients
- Fall 2013: Device for Targeted Ovarian Chemo-Protective Drug Delivery
- Spring 2013: An endo-pouch for selective targeted ovarian drug delivery in cancer patients